Human Tissue Authority (HTA) Call for Evidence

Closed 31 Aug 2015

Opened 14 Jul 2015


In recent years, the health and social care system in England has undergone substantial change. The Health and Social Care Act 2012 and the Care Act 2014 have devolved functions and powers away from the Department of Health to local and Arm’s Length Bodies.

The Department has the key stewardship and assurance function designed to ensure that the new system and multiple new and reformed bodies within it have the appropriate functions and are performing to a high standard.

To perform this stewardship function, the Department has put in place Triennial Reviews of all of its Arm’s Length Bodies. This includes all Executive Non-Departmental Public Bodies (ENDPBs), Advisory Non-Departmental Public Bodies (ANDPBs), Executive Agencies and Special Health Authorities (SpHA). As an Executive Non-Departmental Public Body (ENDPB), the Human Tissue Authority (HTA) is subject to review in 2015-2016.

The programme of reviews builds on the approach developed by the Cabinet Office as part of their work on Public Bodies Reform.

This is a Call for Evidence regarding the Human Tissue Authority (HTA). The focus of this Call for Evidence is on the HTA’s responsibility for regulating the removal, storage and use of human tissue and organs as well as providing approval for organ and bone marrow donations from living people.

Responding to the call for evidence

In order to conduct the review in an open and transparent manner and ensure that the findings are rigorous and evidence-based, the review team is seeking views from a wide range of stakeholders.  We are interested in the views of individuals and organisations that engage with HTA or have a wider interest in its operations.  These stakeholders include, but are not limited to, individuals, researchers, medical practitioners, transplantation organisations, civil society groups, and other health and care institutions.

The call for evidence will run from 14 July 2015 to 31 August 2015. Responses can be provided by:

  1. Completing the online questionnaire
  2. Emailing the review team at
  3. Attending a workshop (see below) where stakeholders can share their views directly with the review team.

Where options ii. or iii. are used, please also consider to what extent the response covers the key lines of enquiry that are set out in the online questionnaire and are replicated below,  It would also be helpful to know the extent of engagement between respondents and the HTA, and the interests represented.

For all options, you do not have to answer all of the questions – please feel free to answer as many or as few as you like. Your evidence should consist of objective, factual information about the impact or effect of the HTA’s approach to health and social care. Where possible, please give specific examples. Where your evidence is relevant to other review reports, we will pass your evidence over to the relevant report teams.

Only information directly relevant to the areas of investigation will be considered. Information where relevance is not demonstrable will not be taken as evidence. The review team is unable to respond to individual cases or consider complaints other than as part of the evidence for the review where it falls within the terms of reference. Complaints should be directed to HTA at or the complaints officer telephone: 020 7269 1900.

Patient identifiable information should not submitted.

Interested stakeholders are also invited to attend workshops to share their views on this Call for Evidence:


                      29 July 2015               10:00 - 12:00 hours             London

12 August 2015               10:00 - 12:00 hours            London

17 August 2015               10:00-12:00 hours            Leeds

Please note: places are limited and will be allocated on a first come first served basis.


Why We Are Consulting

As noted above, this review is part of a wider programme that the Department of Health has developed as part of its stewardship and assurance function.

The review will have two main stages:

  • The first is to provide a robust challenge of the continuing need for the HTA both in terms of the functions it performs, and the way in which these are delivered.
  • If it is agreed that the HTA should retain its current function and utilise the same delivery model, the second stage of the review will then consider its performance, capability and governance, as well as considering opportunities for efficiencies.

This call for evidence seeks views from respondents to assist its consideration of both of the above stages.


  • Voluntary groups
  • Community groups
  • Charities
  • Civil society
  • Advocacy or support organisations
  • GPs
  • Nurses
  • Health visitors
  • Clinicians
  • Managers
  • Commissioners
  • Directors of Public Health
  • Pharmacists
  • Doctors
  • Midwives
  • Healthcare scientists
  • Paramedics
  • Dentists
  • Art therapists
  • Dramatherapists
  • Music therapists
  • Chiropodists/ podiatrists
  • Dieticians
  • Occupational therapists
  • Orthotists
  • Orthopists
  • Prosthetists
  • Physiotherapists
  • Diagnostic radiographers
  • Therapeutic radiographers
  • Speech and language therapists
  • Childcare providers
  • Allied Health Professionals
  • Care-Givers
  • Ophthalmic Practitioners
  • Responsible Officers
  • Foundation Trusts
  • NHS Commissioning Board
  • Tribunal Service
  • Clinical Commissioning Groups
  • Regulatory body
  • Academic/ Professional institution
  • Employer representatives
  • Employee representatives
  • Trade union
  • Deaneries
  • Higher Education institutions
  • Royal Colleges
  • Local authority
  • Social care provider
  • Directors of Adult Social Care Services
  • Members of the public
  • Patients
  • Patients
  • Carers
  • Service users
  • Retailers
  • Suppliers
  • Information providers
  • Information professionals
  • Informatics professionals
  • PCT Cluster CEs
  • NHS Trust CEs
  • SHA Cluster CEs
  • Directors of PH
  • Local Authority CEs
  • Businesses
  • Public Health Organisations
  • Academics
  • Members of the Public
  • Local Authority CEs
  • Allied Health Professionals
  • Childcare providers
  • Early years settings
  • Milk producers
  • Milk suppliers
  • Milk distributers
  • Milk retailers
  • Milk industry bodies


  • Nutrition
  • Children's health and development
  • Physical health
  • Health inequalities
  • Infectious disease
  • Vascular disease
  • Obesity
  • Environment
  • Sexual health
  • Alcohol misuse
  • Drug misuse
  • Public health
  • Health protection
  • Health improvement
  • Immunisation
  • Smoking
  • Public mental health
  • Tobacco
  • Physical activity
  • Public Health England
  • Health premium
  • Well-being
  • NHS Health Checks
  • Screening
  • Prevention
  • Oral public health
  • Health Protection Agency
  • Childcare
  • Health and Social Care Act 2012
  • Primary care
  • Mental health
  • End of life care
  • Maternity services
  • GP consortia
  • Adult social care
  • Carers
  • Dementia
  • Personal health budgets
  • IT
  • Informatics
  • Innovation
  • Education
  • Continuing Professional Development
  • Training
  • Health and well-being boards
  • Funding
  • Commissioning
  • Accountability
  • Transition
  • Health scrutiny
  • NHS Commissioning Board
  • Clinical Governance
  • Performers Lists
  • Complaints
  • Feedback
  • Dairy industry
  • Regulation